Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ACTRN12626000493347) titled 'Efficacy of Prucalopride to Treat Systemic Sclerosis Gastrointestinal Disease' on April 21.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Crossover
Type of endpoint: Efficacy
Primary Sponsor: St Vincent's Hospital Melbourne
Condition:
Systemic sclerosis
Gastrointestinal dysmotility
Systemic sclerosis
Gastrointestinal dysmotility
Inflammatory and Immune System - Connective tissue diseases
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Inte...